HIV Infection Clinical Trial
— HSPOTOfficial title:
The Causal Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
NCT number | NCT02846402 |
Other study ID # | 16-0885 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2016 |
Est. completion date | June 2017 |
Verified date | May 2018 |
Source | Harvard School of Public Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
HSPOT is a cluster-randomized trial designed to determine whether HIV self-tests are acceptable and improve HIV testing rates and HIV status knowledge among female sex workers in Kampala, Uganda. This study will determine whether directly giving participants an HIV self-test or giving them a coupon to collect a test at a drug store or clinic improves outcomes compared to standard of care.
Status | Completed |
Enrollment | 960 |
Est. completion date | June 2017 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years of age or older on the enrollment visit date - Reports exchanging sex (vaginal, anal, and/or oral) for money or goods at least once in the past month - Self-reported HIV negative status and no recent (<3 months) HIV testing OR self-reported HIV unknown status - Member of the hot spot where recruited for at least one month AND plans on remaining in the area for the next 4 months - Have never used an oral HIVST kit - Willing to participate in peer education sessions on a monthly basis over the 4-month study period and to participate in study assessments - Of sound mind and not under influence of drugs or coercion Exclusion Criteria: - Less than 18 years of age on the enrollment date - Has not exchanged any form of sex in the past one month - Self-reported to be living with HIV - Self-reported HIV negative status and reports testing within the last 3 months - Planning to move out of geographic area within 4 months - Concurrently participating in another HIV prevention study - Meets criteria but does not wish to participate - Not willing or able to provide informed consent |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Harvard School of Public Health | International Initiative for Impact Evaluation, International Research Consortium, Uganda Health Marketing Group |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Linkage to HIV care and confirmatory testing | One month from first intervention visit | ||
Other | Linkage to HIV care and confirmatory testing | Four months from first intervention visit | ||
Other | HIV risk perception and beliefs about acquiring HIV | One month from first intervention visit | ||
Other | HIV risk perception and beliefs about acquiring HIV | Four months from first intervention visit | ||
Other | HIV disclosure with sexual partners | One month from first intervention visit | ||
Other | HIV disclosure with sexual partners | Four months from first intervention visit | ||
Other | Condom use with commercial sexual partners since last visit | One month from first intervention visit | ||
Other | Condom use with commercial sexual partners since last visit | Four months from first intervention visit | ||
Other | Condom use with non-commercial sexual partners since last visit | One month from first intervention visit | ||
Other | Condom use with non-commercial sexual partners since last visit | Four months from first intervention visit | ||
Other | Average number of commercial sexual partners | One month from first intervention visit | ||
Other | Average number of commercial sexual partners | Four months from first intervention visit | ||
Other | Average number of non-commercial sexual partners | One month from first intervention visit | ||
Other | Average number of non-commercial sexual partners | Four months from first intervention visit | ||
Other | Intimate partner violence, including sexual, physical, or verbal | One month from first intervention visit | ||
Other | Intimate partner violence, including sexual, physical, or verbal | Four months from first intervention visit | ||
Other | HIV fatalism | One month from first intervention visit | ||
Other | HIV fatalism | Four months from first intervention visit | ||
Other | Self-reported self-efficacy as measured by the General Self Efficacy Scale | One month from first intervention visit | ||
Other | Self-reported self-efficacy as measured by the General Self Efficacy Scale | Four months from first intervention visit | ||
Other | Female sex worker empowerment as measured by Beattie et al 2014 | One month from first intervention visit | ||
Other | Female sex worker empowerment as measured by Beattie et al 2014 | Four months from first intervention visit | ||
Other | Pre-exposure prophylaxis preferences | One month from first intervention visit | ||
Primary | HIV testing in the previous month | One month from first intervention visit | ||
Primary | HIV testing in the previous month | Four months from first intervention visit | ||
Secondary | Knowledge of own HIV status | Four months from first intervention visit | ||
Secondary | HIV self-test kit use in the two intervention arms | One month from first intervention visit | ||
Secondary | HIV self-test kit use in the two intervention arms | Four months from first intervention visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02135419 -
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
|
Phase 3 | |
Active, not recruiting |
NCT02663856 -
My Smart Age With HIV: Smartphone Self-assessment of Frailty
|
||
Completed |
NCT02663869 -
Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
|
||
Completed |
NCT02659306 -
Metformin Immunotherapy in HIV Infection
|
Phase 1 | |
Completed |
NCT02921516 -
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Completed |
NCT02564341 -
Targeting Effective Analgesia in Clinics for HIV - Intervention
|
N/A | |
Active, not recruiting |
NCT02302950 -
A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
|
N/A | |
Completed |
NCT01830595 -
Lactoferrin Treatment in HIV Patients
|
Phase 2 | |
Completed |
NCT02269605 -
Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
|
Phase 1 | |
Completed |
NCT01852942 -
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
Phase 2 | |
Terminated |
NCT02109224 -
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
|
Phase 1 | |
Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
Completed |
NCT02527135 -
Text Messaging to Improve HIV Testing Among Young Women in Kenya
|
N/A | |
Completed |
NCT02118168 -
Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
|
N/A | |
Completed |
NCT01946217 -
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
|
N/A | |
Completed |
NCT02525146 -
Birmingham Access to Care Study
|
N/A | |
Active, not recruiting |
NCT02602418 -
Neural Correlates of Working Memory Training for HIV Patients
|
N/A | |
Completed |
NCT01805427 -
Antiretroviral Therapy and Extreme Weight
|
N/A | |
Completed |
NCT01702974 -
Immune Reconstitution in HIV Disease (IREHIV)
|
Phase 2 |